TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Biokraft Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
22,635
|
21,332
|
19,656 |
Financial expenses |
78,804
|
29,257
|
16,998 |
Earnings before taxes |
-43,370
|
-11,066
|
-10,984 |
EBITDA |
427
|
-1,890
|
-2,819 |
Total assets |
844,529
|
654,808
|
462,066 |
Current assets |
12,396
|
8,001
|
7,660 |
Current liabilities |
146,147
|
61,664
|
33,469 |
Equity capital |
7,140
|
47,163
|
60,034 |
- share capital |
51
|
47
|
49 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
0.8%
|
7.2%
|
13.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
-191.6%
|
-51.9%
|
-55.9% |
Return on assets (ROA) |
4.2%
|
2.8%
|
1.3% |
Current ratio |
8.5%
|
13.0%
|
22.9% |
Return on equity (ROE) |
-607.4%
|
-23.5%
|
-18.3% |
Change turnover |
-211
|
2,267
|
-5,173 |
Change turnover % |
-1%
|
12%
|
-21% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.